Mizuho Lowers Corteva (NYSE:CTVA) Price Target to $71.00

Corteva (NYSE:CTVAGet Free Report) had its target price dropped by stock analysts at Mizuho from $72.00 to $71.00 in a research report issued to clients and investors on Tuesday, MarketBeat reports. The brokerage presently has a “buy” rating on the stock. Mizuho’s target price would suggest a potential upside of 42.31% from the company’s previous close.

Other analysts also recently issued reports about the company. Credit Suisse Group restated an “outperform” rating and issued a $74.00 price objective on shares of Corteva in a report on Friday, August 4th. Argus decreased their price target on shares of Corteva from $78.00 to $68.00 and set a “buy” rating for the company in a research report on Thursday, August 17th. Wells Fargo & Company decreased their price target on shares of Corteva from $74.00 to $73.00 and set an “overweight” rating for the company in a research report on Monday, August 7th. JPMorgan Chase & Co. decreased their price target on shares of Corteva from $70.00 to $65.00 and set an “overweight” rating for the company in a research report on Monday, August 7th. Finally, Canaccord Genuity Group assumed coverage on shares of Corteva in a research report on Wednesday, June 28th. They set a “buy” rating and a $75.00 price target for the company. Four research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, Corteva presently has a consensus rating of “Moderate Buy” and an average price target of $70.35.

Check Out Our Latest Stock Report on Corteva

Corteva Stock Down 1.2 %

Shares of CTVA opened at $49.89 on Tuesday. The firm has a market capitalization of $35.41 billion, a P/E ratio of 38.67, a P/E/G ratio of 1.35 and a beta of 0.79. Corteva has a 12-month low of $48.59 and a 12-month high of $68.43. The company has a current ratio of 1.66, a quick ratio of 1.12 and a debt-to-equity ratio of 0.09. The firm has a fifty day moving average price of $51.23 and a 200-day moving average price of $55.48.

Corteva (NYSE:CTVAGet Free Report) last released its quarterly earnings data on Friday, August 4th. The company reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.58 by $0.02. The firm had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $6.44 billion. Corteva had a return on equity of 7.78% and a net margin of 5.26%. The firm’s quarterly revenue was down 3.2% on a year-over-year basis. During the same period in the previous year, the company posted $1.64 earnings per share. Equities research analysts expect that Corteva will post 2.83 earnings per share for the current year.

Insiders Place Their Bets

In other Corteva news, CFO David J. Anderson purchased 2,000 shares of Corteva stock in a transaction on Friday, September 15th. The stock was bought at an average cost of $52.97 per share, with a total value of $105,940.00. Following the transaction, the chief financial officer now owns 65,308 shares of the company’s stock, valued at approximately $3,459,364.76. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.14% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Corteva

A number of hedge funds and other institutional investors have recently made changes to their positions in CTVA. Cornerstone Planning Group LLC acquired a new stake in shares of Corteva during the 2nd quarter worth approximately $28,000. Barrett & Company Inc. acquired a new stake in Corteva in the 1st quarter valued at $29,000. Blume Capital Management Inc. grew its stake in Corteva by 103.8% in the 2nd quarter. Blume Capital Management Inc. now owns 542 shares of the company’s stock valued at $31,000 after acquiring an additional 276 shares during the period. Perkins Coie Trust Co acquired a new stake in Corteva in the 3rd quarter valued at $31,000. Finally, PCA Investment Advisory Services Inc. acquired a new stake in Corteva in the 2nd quarter valued at $31,000. Institutional investors and hedge funds own 80.56% of the company’s stock.

Corteva Company Profile

(Get Free Report)

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.

Read More

Analyst Recommendations for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.